ArticlePlant molecular biology2025
PbrRALF5/10 prevents incompatible pollen tube death by reconstructing the methyl-esterified pectin and reactive oxygen species metabolism of pear in vitro.
Article in Plant molecular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Rapid alkalinization factors (RALFs) are short-chain polypeptides that regulate methyl-esterified pectin accumulation and reactive oxygen species (ROS) metabolism in pollen tubes across diverse plant species. In pear (Pyrus) self-incompatibility (SI), pollen tube polar growth is inhibited by increased apical methyl-esterified pectin content and disrupted apical ROS gradients, while pear RALF family members show no expression response to SI, indicating they are not inherently involved in the SI regulatory pathway. We investigated pollen tube-highly expressed pear RALFs (PbrRALF2/5/6/7/9/10), among which PbrRALF5/10 interact with pollen tube-expressed PbrLRX7/8/10/11 and negatively regulate apical methyl-esterified pectin content (in contrast to PbrRALF6, which competitively binds PbrLRX8 with PbrRALF10 and exerts opposite pectin-regulatory effects) and positively regulate ROS accumulation via the PbrANX/PbrBUPS receptor kinase pathway. Exogenous application of recombinant PbrRALF5/10 (rPbrRALF5/10) during pear SI responses achieved phenotypic rescue in vitro: it significantly reduced apical methyl-esterified pectin content (not to self-compatible levels), re-established the ROS polarity gradient, alleviated SI-induced nuclear DNA degradation, and alleviated incompatible pollen tube growth inhibition. These findings, based on exclusive in vitro experiments, clarify that PbrRALF5/10, while not participating in the SI pathway, mitigate SI-induced pollen tube defects by regulating pectin and ROS, providing insights into their potential for improving pear reproductive success. Notably, in vivo validation remains critical to fully support these conclusions, as no in vivo evidence was obtained to confirm the function of PbrRALF5/10 in alleviating SI under natural pollination conditions.
Indexed as
Identifiers
41428106What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.